Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
Adds five years of market exclusivity on approval
On track to complete the BLA submission in the first half of 2022
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
